Emergent BioSolutions | 税前利润



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


税前利润 更改 日
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -8.12M 5.34M 2025-09
ANI Pharmaceuticals USD 49.52M 39M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Coherus Biosciences USD -47.4M 14.9M 2025-03
Exact Sciences USD -17.76M 17.7M 2025-09
Exelixis USD 252.69M 275K 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Lonza CHF 624M 197M 2024-12
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Myriad Genetics USD 6.2M 2.1M 2024-12
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Pacira USD -1.93M 10.63M 2025-06
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
United Therapeutics USD 438M 29.6M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Xoma USD 15.98M 24.58M 2024-06


Emergent BioSolutions 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.